Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1
Authors:
- Alexander SkorokhodASAlexander Skorokhod
- David CapperDCDavid Capper
- Andreas von DeimlingADAndreas von Deimling
- Alexander EnkAEAlexander Enk
- Peter HelmboldPHPeter Helmbold
- 1 September 2012
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 67 (3) , 488-491
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyActa Neuropathologica, 2011
- Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysisBritish Journal of Dermatology, 2010
- How melanomas bypass new therapyNature, 2010
- Application of a BRAF Pyrosequencing Assay for Mutation Detection and Copy Number Analysis in Malignant MelanomaThe Journal of Molecular Diagnostics, 2007